Welcome to Library
Annual Reports
RMRIMS News Bulletine
Publications List of Dr. Chandra Shekhar Lal

 

60

Rabi Das VN, Siddiqui NA, Pal B, Lal CS, Verma N, Kumar A, Verma RB, Kumar D, Das P and Pandey K. To evaluate efficacy and safety of amphotericin B in two different doses in the treatment of post kala-azar dermal leishmaniasis (PKDL). PLoS One. 2017 Mar 29;12(3):e0174497. doi: 10.1371/journal.pone.0174497. eCollection 2017.

59

Pandey K, Pal B, Das VN, Murti K, Lal CS, Verma N, Bimal S, Ali V, Verma RB, Topno RK, Siddiqi NA and Das P. Safety and efficacy of a combination of Paromomycin and Miltefosine for two versus three courses in patients with Post Kala-Azar Dermal Leishmaniasis (PKDL) - an observational pilot Study. Br J Dermatol. 2017; 177(2):557-559. doi: 10.1111/bjd.15119. Epub 2017 Jul 2.

58

Kumari A, Singh KP, Mandal A, Paswan RK, Sinha P, Das P, Ali V, Bimal S and Lal CS. Intracellular zinc flux causes reactive oxygen species mediated mitochondrial dysfunction leading to cell death in Leishmania donovani. PLoS One. 2017 Jun 6;12(6):e0178800. doi: 10.1371/journal.pone.0178800. eCollection 2017.

57

Pal B, Murti K, Siddiqui NA, Das P, Lal CS, Babu R, Rastogi MK and Pandey K. Assessment of quality of life in patients with post kalaazar dermal leishmaniasis. Health Qual Life Outcomes. 2017; 15(1): 148. doi: 10.1186/s12955-017-0720-y.

56

Kumari A, Singh KP, Mandal A, Paswan RK, Sinha P, Das P, Ali V, Bimal S and Lal CS. Intracellular zinc flux causes reactive oxygen species mediated mitochondrial dysfunction leading to cell death in Leishmania donovani. PLoS One. 2017; 12(6): e0178800. doi: 10.1371/journal.pone.0178800. eCollection 2017.

55

Paswan RK, Bimal S, Kumari A, Sinha P, Das VN, Pandey K, Kumar S, Verma RB, Das P and Lal CS. Reduced High Density Lipoprotein Concentration Modulates Increased Interleukin-10 and Decreased Interferon-Gamma in Visceral Leishmaniasis Patients. Gen Med (Los Angel) 2016; 4:233. doi:10.4172/2327-5146.1000233.

 

54

Sinha P, Paswan RK, Kumari A, Kumar S, Bimal S, Das P and Lal CS. Magnesium-Dependent Ecto-ATP Diphosphohydrolase Activity in Leishmania donovani. Curr Microbiol. 2016; 73(6): 811-819.

53

Siddiqui NA, Rabidas VN, Sinha SK, Verma RB, Pandey K, Singh VP, Ranjan A, Topno RK, Lal CS, Kumar V, Sahoo GC, Sridhar S, Pandey A and Das P. Snowball Vs. House-to-House Technique for Measuring Annual Incidence of Kala-azar in the Higher Endemic Blocks of Bihar, India: A Comparison. PLoS Negl Trop Dis. 2016; 10(9): e0004970. doi: 10.1371/journal.pntd.0004970.

52

Das S, Mandal R, Rabidas VN, Verma N, Pandey K, Ghosh AK, Kesari S, Kumar A, Purkait B, Lal CS and Das P. Chronic Arsenic Exposure and Risk of Post Kala-azar Dermal Leishmaniasis Development in India: A Retrospective Cohort Study. PLoS Negl Trop Dis. 2016; 10(10): e0005060. doi: 10.1371/journal.pntd.0005060.

51

Kumar R, Das VN, Topno RK, Pal B, Imam A, Agrawal K, Singh A, Murti K, Lal CS, Verma N, Das P and Pandey K. Para-kala-azar dermal Leishmaniasis cases in Indian subcontinent - A case series. Pathog Glob Health. 2016; 110(7-8): 326-329. No abstract available.

50
Lal CS, Verma RB, Verma N, Siddiqui NA, Rabidas VN, Pandey K, Singh D, Kumar S, Paswan RK, Kumari A, Sinha P and Das P. Hypertriglyceridemia: a possible diagnostic marker of disease severity in visceral leishmaniasis. Infection. 2016; 44(1): 39-45. doi: 10.1007/s15010-015-0811-9. (Epub 2015 Jul 10).
49
Verma N, Bimal S, Das VNR, Pandey K, Singh D, Lal CS, Singh AS, Sinha PK and Das P. Clinicopathological and Immunological Changes in Indian Post Kala-Azar Dermal Leishmaniasis (PKDL) Cases in relation to Treatment: A Retrospective Study. BioMed Research International 2015; Article ID 745062. http://dx.doi.org/10.1155/2015/745062
 
48
Pandey K, Singh D, Bimal S, Rabidas V, Murti K, Lal CS and Das P. Newer drugs for Visceral Leishmaniasis: a review. American Journal of Infectious Diseases, 2014; 10 (2): 68-70.
 
47
Sundar S, Pandey K, Thakur CP, Jha TK, Das VN, Verma N, Lal CS, Verma D, Alam S and Das P. Efficacy and Safety of Amphotericin B Emulsion versus Liposomal Formulation in Indian Patients with Visceral Leishmaniasis: A Randomized, Open-Label Study. PLoS Negl Trop Dis. 2014; 8(9): e3169. doi: 10.1371/journal.pntd.0003169.
46
Kumar V, Bimal S, Singh SK, Chaudhary R, Das S, Lal C, Pandey K, Das VR and Das P. Leishmania donovani: Dynamics of L. donovani evasion of innate immune cell attack due to malnutrition in visceral leishmaniasis. Nutrition. 2014; 30(4): 449-458.

45.

Verma N, Singh D, Pandey K, Das VN, Lal CS, Verma RB, Sinha PK and Das P. Comparative Evaluation of PCR and Imprint Smear Microscopy of Skin Biopsy in Diagnosis of Macular, Papular and Mixed Papulo-nodular Lesions of PKDL. J Clin Microbiol. 2013; 51(12): 4217-4219. doi: 10.1128/JCM.01482-13. (Epub 2013 Sep 25).

44.

Pandey K, Singh D, Lal C S, Das V, Das P. Fatal acute pancreatitis in a patient with visceral leishmaniasis during miltefosine treatment. J Postgrad Med. 2013; 59(4): 306-308. doi: 10.4103/0022-3859.123161.

43.

Verma N, Lal CS, Rabidas V, Pandey K, Singh D, Kumar S, Verma RB and Das P. Microalbuminuria and glomerular filtration rate in paediatric visceral leishmaniasis. Biomed Res Int. 2013; 2013: 498918. doi: 10.1155/2013/498918. (Epub 2013 Jun 23).

42.

Das V, Pandey K, Singh D, Forwood C, Lal CS and Das P. Development of post-kala-azar dermal leishmaniasis in AmBisome treated visceral leishmaniasis: A possible challenge to elimination program in India. J Postgrad Med. 2013; 59(3): 226-228. doi: 10.4103/0022-3859.118046.

41.

Lal CS, Kumar S, Ranjan A, Rabidas VN, Verma N, Pandey K, Verma RB, Das S, Singh D and Das P. Comparative analysis of serum zinc, copper, magnesium, calcium and iron level in acute and chronic patients of visceral leishmaniasis. J Trace Elem Med Biol. 2013; 27(2): 98-102. doi: 10.1016/j.jtemb.2012.09.007. (Epub 2012 Nov 28).

40.

Singh D, Pandey K, Das VN, Das S, Verma N, Ranjan A, Lal CS, Topno KR, Singh SK, Verma RB, Kumar A, Sardar AH, Purkait B and Das P. Evaluation of rK-39 Strip Test Using Urine for Diagnosis of Visceral Leishmaniasis in an Endemic Region of India.  Am Am J Trop Med Hyg. 2013; 88(2): 222-226. doi: 10.4269/ajtmh.2012.12-0489. (Epub 2012 Nov 13).

39.

Muniaraj M, Kumar S, Lal CS and Sinha PK. Biochemical Profile of Milk of Buffalo (Bubalus bubalis), Cow (Bos taurus) and Goat (Capra hircus): Potential Candidates for Supporting the Growth of Leishmania donovani Promastigotes in Culture Medium as Alternative to Fetal Bovine Serum (FBS). Journal of Buffalo Sciences, 2012; 1(2): 174-176.

38.

Das VNR, Ranjan A, Pandey K, Singh D, Verma N, Das S, Lal CS, Sinha NK, Verma RB, Siddiqui NA, and Das P. Short Report: Clinico-Epidemiologic Profile of a Cohort of Post–Kala-Azar Dermal Leishmaniasis Patients in Bihar, India. Am. J. Trop. Med. Hyg., 2012; 86(6): 959–961.

37.

Pandey K, Das VN, Singh D, Das S, Lal CS, Verma N, Bimal S, Topno RK, Siddiqui NA, Verma RB, Sinha PK and Das P. Post-kala-azar dermal leishmaniasis in a patient treated with injectable paromomycin for visceral leishmaniasis in India. J Clin Microbiol. 2012; 50(4): 1478-1479. (Epub 2012 Jan 25).

36.

Sundar S, Sinha PK, Rai M, Verma DK, Nawin K, Alam S, Chakravarty J, Vaillant M, Verma N, Pandey K, Kumari P, Lal CS, Arora R, Sharma B, Ellis S, Strub-Wourgaft N, Balasegaram M, Olliaro P, Das P and Modabber F. Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial. Lancet, 2011; 377(9764): 477-486. (Epub 2011 Jan 20).

 

35.

Ghosh J, Lal CS, Pandey K, Das VN, Das P, Roychoudhury K and Roy S. Human visceral leishmaniasis: decrease in serum cholesterol as a function of splenic parasite load. Ann Trop Med Parasitol., 2011; 105(3): 267-271.

34.

Kumar N, Sinha PK, Pandey K, Verma N, Lal CS, Ranjan A, Verma RB and Das P. A rare case of Visceral leishmaniasis with multiple relapse and multi-drug unresponsive: successfully treated with combination therapy. International Journal of Clinical Pharmacy, 2011; Jul 22. [Epub ahead of print].

33.

Sundar S, Sinha PK, Rai M, Verma DK, Nawin K, Alam S, Chakravarty J, Vaillant M, Verma N, Pandey K, Kumari P, Lal CS, Arora R, Sharma B, Ellis S, Strub-Wourgaft N, Balasegaram M, Olliaro P, Das P and Modabber F. Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial. Lancet, 2011; 377(9764): 477-486. (Epub 2011 Jan 20).

 

32.

Das VNR, Pandey K, Verma N, Bimal S, Lal CS, Singh D and Das P. Post-kala-azar dermal leishmaniasis(PKDL), HIV and pulmonary tuberculosis . National Medical Journal of India. 2010; 23(2): 88-89.

31.

Lal CS, Verma N, Rabidas VN, Ranjan A, Pandey K, Verma RB, Singh D, Kumar S and Das P. Total serum cholesterol determination can provide understanding of parasite burden in patients with visceral leishmaniasis infection. Clin Chim Acta. 2010; 411(23-24): 2112-2113. (Epub 2010 Sep 8).

30.

Das VN, Pandey K, Verma N, Lal CS, Bimal S, Topno RK, Singh D, Siddiqui NA, Verma RB and Das P. Development of Post Kala-Azar Dermal Leishmaniasis (PKDL) in Miltefosinetreated visceral leishmaniasis. American Journal of Tropical Medicine and Hygiene, 2009; 80(3): 336-338.


29.

Banerjee S, Ghosh J, Sen S, Guha R, Dhar R, Ghosh M, Datta S, Raychaudhury B, Naskar K, Haldar AK, Lal CS, Pandey K, Das VN, Das P and Roy S. Designing therapies against experimental visceral leishmaniasis by modulating the membrane fluidity of antigen-presenting cells. Infection and immunity, 2009; 77(6): 2330-2342.


28.

Lal CS, Topno RK, Siddiqui NA, Singh D and Das P. Tuberous sclerosis with visceral leishmaniasis: a case report. Journal of Medical Case Reports, 2009; 3: 9027.

 

27.

Sinha PK, Bimal S, Pandey K, Singh SK, Ranjan A, Kumar N, Lal CS, Barman SB, Verma RB, Jeyakumar A, Das P, Bhattacharya M, Sur D and Bhattacharya SK. A community-based, comparative evaluation of direct agglutination and rK39 strip tests in the early detection of subclinical Leishmania donovani infection. Ann. Trop. Med. & Parasitol, (2008); 102(2): 119-125.

26.

Kumar N, Pandey K, Das VN, Sinha PK, Topno RK, Lal CS, Bimal S, Verma N and Das P. HIV infection, visceral leishmaniasis and Guillain –Barre syndrome in same patient: a case report. Ann. Trop. Med. & Parasitol, 2008; 102(2): 185-188.

25.

Pandey K, Sinha PK, Rabidas V, Kumar N, Bimal S, Verma N, Lal C and Das P. HIV, visceral leishmaniasis and Parkinsonism combined with diabetes mellitus and hyperuricaemia: A case report. Cases Journal, 2008; 1: 183.


24.

Narayan S, Gupta AK, Singh Subhankar K, Lal CS, Singh VP, Sinha PK, Das P and Thakur CP. Clinical and Laboratory comparision of different brands of Amphotericin B used for the treatment of kala-azar. Journal of Communicable Diseases, 2008; 40(4): 273-276.


23.

Muniaraj M, Lal CS, Kumar S, Sinha PK and Das P. Milk of cow (Bos taurus), buffalo (Bubalus bubalis), and goat (Capra hircus): a better alternative than fetal bovine serum in media for primary isolation, in vitro cultivation, and maintenance of Leishmania donovani promastigotes. J. Clin. Microbiol,  2007; 45(4): 1353-1356.


22.

Kumar N, Pandey K, Das VN, Sinha PK, Topno RK, Verma N, Lal CS, Das P and Bhattacharya SK. Miltefosine in the Treatment of a case of Visceral Leishmaniasis with Renal Dysfunction. Ann Trop Med Parasitol, 2007; 101(7): 649-651.

21.

Bhattacharya SK, Sinha PK, Sundar S, Thakur CP, Jha TK, Pandey K, Das VR, Kumar N, Lal C, Verma N, Singh VP, Ranjan A, Verma RB, Anders G, Sindermann H and Ganguly NK. Phase IV Trial of Miltefosine in the Treatment of Indian Visceral Leishmaniasis. J Infect Dis, 2007;196(4): 591-598.


20.

Lal CS, Kumar A, Kumar S, Pandey K, Kumar N, Bimal S, Sinha PK and Das P. Hypocholesterolemia and increased triglycerides in paediatric visceral leishmaniasis. Clinica Chimica Acta, 2007; 382(1-2): 151-153.


19.

Pandey K, Sinha PK, Das VN, Kumar N, Verma N, Bimal S, Lal CS, Topno RK, Singh D, Verma RB, Bhattacharya SK and Das P. Wilson Disease with Visceral Leishmaniasis: An Extremely Uncommon Presentation. Am J Trop Med Hyg, 2007; 77(3): 560 – 561.

18.

Sinha PK, Ranjan A, Singh VP, Das VNR, Pandey K, Kumar N, Verma N, Lal CS, Sur D, Manna B and Bhattacharya SK. Visceral Leishmaniasis (Kala-azar)-the Bihar (India) perspective. J Infect, 2006; 53(1): 60-64.

17.

Das VN, Pandey K, Kumar N, Hassan SM, Bimal S, Lal CS, Siddiqui NA and Bhattacharya SK. Visceral leishmaniasis and tuberculosis in patients with HIV co-infection. Southeast Asian J Trop Med Public Health, 2006; 37(1): 18-21.


16.

Pandey K, Sinha PK, Das VN, Kumar N, Hassan SM, Verma N, Lal CS, Bimal S, Das P and Bhattacharya SK. HIV-I infection, visceral leishmaniasis, Koch's chest and tuberculous meningitis in the same patient- a case report. Ann Trop Med Parasitol, 2005; 99(8): 807-811.

15.

Ranjan A, Sur D, Singh VP, Siddique NA, Manna B, Lal CS, Sinha PK, Kishore K and Bhattacharya SK. Risk factors for Indian Kala–Azar. Am J Trop Med Hyg, 2005; 73(1): 74-78.


14.

Lal CS, Kumar V, Ranjan A, Das VN, Kumar N, Kishore K and Bhattacharya SK. Evaluation of Cholinesterase level in an endemic population exposed to Malathion Suspension Formulation as a vector control measure. Memorias Do Instituto Oswaldo Cruz, 2004; 99(2): 219-221.


13.

Kishore K, Kumar V, Lal CS, Kesari SK, Das P and Bhattacharya SK. Estimation of efficacy of malathion (SRES) against phlebotomus argentipes the vector of Indian kala-azar, with the help of bioassay and HPLC analysis. Journal of Tropical Medicine & Hygiene, 2002; 20: 13.

 

12.

Das VN, Ranjan A, Sinha AN, Verma N, Lal CS, Gupta AK, Siddiqui NA and Kar SK. A randomized clinical trial of low dosage combination of pentamidine and allopurinol in the treatment of antimony unresponsive cases of visceral leishmaniasis. Journal of Association of Physician of India, 2001; 49: 609-613.

11.

Bimal S, Bagchi AK, Das V, Sinha PK, Lal CS, Ranjan A, Gupta AK and Kar SK. Effect of immunization with lipid associated polysaccharide antigen and anti CD-2 antibodies on class II MHC expression and cellular immune response in BALB/C mice infected with leishmania donovani. Indian Journal of Experimental Biology, 2001; 39: 878-882.

10.

Lal CS, Gupta AK, Das VNR, Verma N, Sinha NK, Singh R, Palit A and Kar SK. Isoenzyme typing of Leishmania parasites in different geographical distribution in Bihar. Journal of Parasitic Diseases, 1999; 23(1): 27.

 

9.

Lal CS, Ranjan A and Kar SK. Effect of extraneous uric acidon the growth of promastigotes of L.donovani in -vitro. Journal of Parasitic Diseases, 1999; 23(1): 55.

 

8.

Palit A, Kishore K, Kesari S, Kumar V, Ranjan A, Lal CS and Kar SK.  Studies on host preference of two species of Phlebotomus flies, Phlebotomus argentipes and Phlebotomus papatasi (Diptera :Psychodidae) in Bihar, India. Journal of Parasitic Diseases, 1999; 23(1): 117.

 

7.

Bimal S, Lal SL, Lal CS, Singha UK, Saran R, Sen AB and Sahay VK. Reversal of T-cell unresponsiveness through serine-esterase inhibitors mediated enhanced lymphokine induced microbicidal activities in kala-azar. Indian Journal of Exp. Biology, 1992; 30: 54-56.

6.

Bimal S, Lal SL, Lal CS, Singha UK, Saran R, Sen AB and Sahay VK. Reversal of T-cell unresponsiveness through serine-esterase inhibitors mediated enhanced lymphokine induced microbicidal activities in kala-azar. Indian Journal of Exp. Biology, 1992; 30: 54-56.

5.

Lal S, Lal CS, Sinha SP, Bimal S, Lal AHB and Saran R.  Study of acid phosphatase to assess host parasite relationship in visceral leishmaniasis. Indian Journal of Comparative Microbiology, Immunology and Infectious Diseases, 1992; 13(3&4): 94-99.

4.

Lal S, Lal CS, Sinha SP, Bimal S, Lal AHB and Saran R.  Study of acid phosphatase to assess host parasite relationship in visceral leishmaniasis. Indian Journal of Comparative Microbiology, Immunology and Infectious Diseases, 1992; 13(3&4): 94-99.

3.

Bimal S, Lal SL, Lal CS, Singha UK, Sen AB and Sahay VK. Enhancement of MIF activity of T-cell mitogen to assess its role in provocating acid phosphatase relaease from macrophage in visceral leishmaniasis. Indian Journal of Parasitology, 1991; 15(1). 153.

 

2.

Bimal S, Lal SL, Lal CS, Verma N and Sinha AN. Study of Host Immune System during course of L.donovani infection. Indian Journal of Parasitology, 1991; 15(1): 53-56.

 

1.

Bimal S, Lal SL, Lal CS and Sinha AN. Analysis of different macrophage population to study role of macrophage in generation of specific immune protection in Visceral Leishmaniasis. Indian journal of Parasitology, 1990; 14(2): 191-195.